SLI
2.047,46
PKT
+6,60
PKT
+0,32
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.12.22 | Nestlé Neutral | Credit Suisse Group | |
| 19.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 19.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 19.12.22 | Givaudan Sell | UBS AG | |
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Givaudan Hold | Deutsche Bank AG | |
| 15.12.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 14.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 14.12.22 | Roche Neutral | UBS AG | |
| 13.12.22 | Nestlé Neutral | Credit Suisse Group | |
| 13.12.22 | Givaudan Sell | UBS AG | |
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 09.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 09.12.22 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 09.12.22 | UBS Neutral | Credit Suisse Group | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 08.12.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.12.22 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 06.12.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 05.12.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.12.22 | Nestlé Market-Perform | Bernstein Research | |
| 05.12.22 | UBS Buy | Jefferies & Company Inc. | |
| 02.12.22 | Swiss Re Sell | UBS AG | |
| 02.12.22 | Zurich Insurance Buy | UBS AG | |
| 02.12.22 | Nestlé Hold | Deutsche Bank AG | |
| 02.12.22 | Roche Hold | Deutsche Bank AG | |
| 01.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 01.12.22 | Nestlé Hold | Deutsche Bank AG | |
| 01.12.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 01.12.22 | Givaudan Underweight | JP Morgan Chase & Co. |